Prostate biopsy (PBx) techniques have changed significantly since the original Hodge's scheme.
Although the use of transrectal ultrasound (TRUS) guided (PBx) is considered the gold standard for the diagnosis of prostate cancer (Pca), the strategies for initial and repeat biopsies remain controversial. Even with the widespread application of extended prostate biopsy (ePBx) protocols, the false negative rate remains substantial and early PCa detection remains limited. Optimization of the PBx procedures reduce the likelihood of facing a "repeat biopsy dilemma". The aim of this review is to provide an evidence-based update on current methods of PBx and discuss the strategies to optimise biopsy procedures.
Written by:
Bostancı Y, Kazzazı A, Djavan B. Are you the author?
New York University School of Medicine, New York, NY, USA.
Reference: Minerva Urol Nefrol. 2012 Dec;64(4):233-43.
PubMed Abstract
PMID: 23288210
UroToday.com Prostate Cancer Section
